AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 175 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 1.29 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $4,926,000 | +28.0% | 80,025 | +40.5% | 0.03% | +28.0% |
| Q2 2018 | $3,848,000 | +40.3% | 56,967 | +12.7% | 0.02% | +13.6% |
| Q1 2018 | $2,743,000 | +12.9% | 50,556 | +24.3% | 0.02% | +29.4% |
| Q4 2017 | $2,430,000 | +39.7% | 40,673 | +13.6% | 0.02% | +41.7% |
| Q3 2017 | $1,739,000 | +3.6% | 35,790 | +12.1% | 0.01% | 0.0% |
| Q2 2017 | $1,678,000 | +28.9% | 31,934 | +11.2% | 0.01% | +33.3% |
| Q1 2017 | $1,302,000 | +7.2% | 28,718 | -10.5% | 0.01% | 0.0% |
| Q4 2016 | $1,214,000 | -9.5% | 32,080 | -9.8% | 0.01% | -18.2% |
| Q3 2016 | $1,342,000 | +104.6% | 35,558 | -4.6% | 0.01% | +83.3% |
| Q2 2016 | $656,000 | +81.7% | 37,268 | +25.7% | 0.01% | +50.0% |
| Q1 2016 | $361,000 | -57.3% | 29,650 | -14.6% | 0.00% | -50.0% |
| Q4 2015 | $846,000 | -88.1% | 34,732 | -13.6% | 0.01% | 0.0% |
| Q3 2015 | $7,134,000 | +1503.1% | 40,215 | +59.5% | 0.01% | +100.0% |
| Q2 2015 | $445,000 | +19.0% | 25,207 | +111.4% | 0.00% | +33.3% |
| Q1 2015 | $374,000 | – | 11,923 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|